Get Screened: Top Message from Colorectal Cancer Surgeon and Patient

2024-03-25
CENTER VALLEY, Pa., March 25, 2024 /PRNewswire/ -- Colorectal cancer is highly preventable with screening. Furthermore, localized colorectal cancer has a 91% five-year survival rate with treatment.i
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9154152-olympus-sponsors-colorectal-cancer-awareness-importance-of-early-screening/
Continue Reading
Get Screened: Top Message from Colorectal Cancer Surgeon and Patient
Preview
来源: PRNewswire
Cedrek McFadden, MD, is a board-certified colorectal and general surgeon and a member of the CCA Medical Scientific Advisory Committee. He treats large intestine disorders, including colorectal cancer, inflammatory bowel disease, diverticular disease, and hemorrhoids. He performs colonoscopies and minimally invasive and robotic surgery. He regularly appears on television as a medical and wellness contributor.
Get Screened: Top Message from Colorectal Cancer Surgeon and Patient
Preview
来源: PRNewswire
Dr. Cedrek McFadden and colorectal cancer survivor Amishi Shah, PharmD, on the set of the Satellite Media Tour, hosted by the Colorectal Cancer Alliance and sponsored by Olympus Corporation of the Americas.
Colorectal cancer often develops without symptoms, and in 2024 an estimated 152,810 people in the U.S. will be diagnosed and an estimated 53,010 will die from it — making this disease the second-leading cause of cancer deaths in the U.S. for men and women combined, and the deadliest cancer among men under 50.ii
Researchers predict colorectal cancer will become the leading cause of cancer death in men and women ages 20-49 by 2030.iii According to the National Cancer InstituteCancer Institute, the rate of colorectal cancer in adults younger than 50 has been rising steadily since the 1990s.iv The reason behind this rise is unclear.
On-time screening is essential to catch this disease early and also help prevent it, facts colorectal surgeon Dr. Cedrek McFadden and colorectal cancer survivor Amishi Shah, PharmD, emphasized to reporters across the country during their satellite media tour (SMT) in New York City on March 5, 2024. Both are available for interview.
Sponsored by Olympus Corporation of the Americas and hosted by the Colorectal Cancer Alliance, the SMT brought the important message about screening to more than 7 million people nationwide. During National Colorectal Cancer Awareness Month, all generations should visit GetScreened.org to learn about risk factors, symptoms, and screening options that could make a difference between life and death.
About Olympus
At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more information, visit olympusamerica.com.
__________________________
i Survival Rates for Colorectal Cancer. Cancer.org. https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html. Last updated January 29, 2024. Accessed March 19, 2024.
ii Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1): 12-49. doi:10.3322/caac.21820
iii Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open. 2021;4(4):e214708. doi:10.1001/jamanetworkopen.2021.4708
iv Why Is Colorectal Cancer Rising Rapidly among Young Adults? Cancer.gov. https://www.cancer.gov/news-events/cancer-currents-blog/2020/colorectal-cancer-rising-younger-adults. Published November 5, 2020. Accessed March 19, 2024.
SOURCE Olympus Corporation of the Americas
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。